It is possible that targeting a combination of targets, such as CLL-1, CD33 and CD123 might be most effective in JMML even though CD33 and CD123 did not pass the filters in our bioinformatic pipeline. Here, CLEC12A is linked to juvenile myelomonocytic leukemia.